Equities

Consun Pharmaceutical Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Consun Pharmaceutical Group Ltd

Actions
  • Price (EUR)1.93
  • Today's Change-0.09 / -4.46%
  • Shares traded77.00
  • 1 Year change+120.57%
  • Beta0.6559
Data delayed at least 15 minutes, as of Feb 20 2026 09:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments3,8663,5833,039
Total Receivables, Net370310296
Total Inventory290367276
Prepaid expenses261812
Other current assets, total----0
Total current assets4,5514,2783,623
Property, plant & equipment, net798739746
Goodwill, net------
Intangibles, net269283312
Long term investments432422
Note receivable - long term------
Other long term assets------
Total assets5,8535,5084,892
LIABILITIES
Accounts payable768360
Accrued expenses736639566
Notes payable/short-term debt253503451
Current portion long-term debt/capital leases6.424.223.71
Other current liabilities, total299266270
Total current liabilities1,3711,4951,350
Total long term debt7.413.905.95
Total debt267512460
Deferred income tax677178
Minority interest295292294
Other liabilities, total151919
Total liabilities1,7551,8811,747
SHAREHOLDERS EQUITY
Common stock676463
Additional paid-in capital216180
Retained earnings (accumulated deficit)3,8123,5433,080
Treasury stock - common--00
Unrealized gain (loss)------
Other equity, total2.021.842.08
Total equity4,0983,6273,145
Total liabilities & shareholders' equity5,8535,5084,892
Total common shares outstanding849811807
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.